Madan Jagasia, MBBS, MS, on Ruxolitinib to Treat Steroid Refractory GvHD
2020
Madan Jagasia, MBBS, MS, of the Vanderbilt University Medical Center discussed the next steps in treating acute graft versus host disease with ruxolitinib.
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI